| SPANJAART, AM, P LJUNGMAN, La Camara R DE, G TRIDELLO, V ORTIZ-MALDONADO, A URBANO-ISPIZUA, P BARBA, M KWON, D CABALLERO, P SESQUES, E BACHY, Blasi R DI, C THIEBLEMONT, F CALKOEN, P MUTSAERS, J MAERTENS, L GIANNONI, E NICHOLSON, M COLLIN, CP VAZ, E METAFUNI, J MARTINEZ-LOPEZ, FL DIGNAN, JM RIBERA, A NAGLER, František FOLBER, R SANDERSON, A BLOOR, F CICERI, N KNELANGE, F AYUK, N KROGER, MJ KERSTEN and S MIELKE. Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group. Leukemia. London: Nature Publishing Group, 2021, vol. 35, No 12, p. 3585-3588. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-021-01466-0. |
Other formats:
BibTeX
LaTeX
RIS
@article{1810318,
author = {Spanjaart, AM and Ljungman, P and de, La Camara R and Tridello, G and OrtizandMaldonado, V and UrbanoandIspizua, A and Barba, P and Kwon, M and Caballero, D and Sesques, P and Bachy, E and Di, Blasi R and Thieblemont, C and Calkoen, F and Mutsaers, P and Maertens, J and Giannoni, L and Nicholson, E and Collin, M and Vaz, CP and Metafuni, E and MartinezandLopez, J and Dignan, FL and Ribera, JM and Nagler, A and Folber, František and Sanderson, R and Bloor, A and Ciceri, F and Knelange, N and Ayuk, F and Kroger, N and Kersten, MJ and Mielke, S},
article_location = {London},
article_number = {12},
doi = {http://dx.doi.org/10.1038/s41375-021-01466-0},
language = {eng},
issn = {0887-6924},
journal = {Leukemia},
note = {Bez afiliace k MU.},
title = {Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group},
volume = {35},
year = {2021}
}
TY - JOUR
ID - 1810318
AU - Spanjaart, AM - Ljungman, P - de, La Camara R - Tridello, G - Ortiz-Maldonado, V - Urbano-Ispizua, A - Barba, P - Kwon, M - Caballero, D - Sesques, P - Bachy, E - Di, Blasi R - Thieblemont, C - Calkoen, F - Mutsaers, P - Maertens, J - Giannoni, L - Nicholson, E - Collin, M - Vaz, CP - Metafuni, E - Martinez-Lopez, J - Dignan, FL - Ribera, JM - Nagler, A - Folber, František - Sanderson, R - Bloor, A - Ciceri, F - Knelange, N - Ayuk, F - Kroger, N - Kersten, MJ - Mielke, S
PY - 2021
TI - Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group
JF - Leukemia
VL - 35
IS - 12
SP - 3585-3588
EP - 3585-3588
PB - Nature Publishing Group
SN - 08876924
N1 - Bez afiliace k MU.
ER -
SPANJAART, AM, P LJUNGMAN, La Camara R DE, G TRIDELLO, V ORTIZ-MALDONADO, A URBANO-ISPIZUA, P BARBA, M KWON, D CABALLERO, P SESQUES, E BACHY, Blasi R DI, C THIEBLEMONT, F CALKOEN, P MUTSAERS, J MAERTENS, L GIANNONI, E NICHOLSON, M COLLIN, CP VAZ, E METAFUNI, J MARTINEZ-LOPEZ, FL DIGNAN, JM RIBERA, A NAGLER, František FOLBER, R SANDERSON, A BLOOR, F CICERI, N KNELANGE, F AYUK, N KROGER, MJ KERSTEN and S MIELKE. Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group. \textit{Leukemia}. London: Nature Publishing Group, 2021, vol.~35, No~12, p.~3585-3588. ISSN~0887-6924. Available from: https://dx.doi.org/10.1038/s41375-021-01466-0.
|
